From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.
Partner News | Published: Thursday, July 30, 2020Practice Profile 8 clinics located across Central Virginia 43 providers Problem: When offices become quiet COVID-19 marked the end of business as usual. In mid-March, Virginia Cardiovascular Specialists
Partner News | Published: Monday, July 27, 2020
Moving Analytics, a virtual cardiovascular disease management company that works with payers and providers to improve the health outcomes and cost of their cardiovascular populations.
Partner News | Published: Thursday, July 9, 2020
Learn how ScImage’s PICOM365 provides a turnkey end-to-end solution for data and image integration in this white paper that was developed in partnership with ScImage. Hear from MedAxiom members that have chosen their solution and the benefits they have experienced in workflows and overall work-life balance.
Partner News | Published: Thursday, June 4, 2020By: Robert J. Zasa, CEO, ACA Cardiovascular, LLC and firstname.lastname@example.org Heather Combs, RN , COO, ACA Cardiovascular email@example.com Interventional cardiovascular
Partner News | Published: Monday, June 1, 2020
Cell>Point, LLC. is a leader in the development and commercialization of molecular imaging and targeted therapeutics.
Partner News | Published: Wednesday, May 20, 2020
Many factors influence your decision to execute a sale-leaseback of your building, including deal terms, asset location, strength of the practice, and tenure of the physicians. In this white paper from Physicians Realty Trust, a trusted industry partner, learn what factors to consider as you determine if the timing is right to look at a potential sale-leaseback for your real estate.
Partner News | Published: Wednesday, May 13, 2020Genetesis Inc, a MedAxiom partner and medical technology company that has developed non-invasive, biomagnetic CardioFlux™ imaging, has announced several important updates. The company has closed
Partner News | Published: Monday, May 11, 2020Medical practices are working through multiple issues brought on by the COVID-19 pandemic: supplying needed care for patients, uncertainties in staffing, PPE supply, PPP funding, and preserving revenue. Some
Partner News | Published: Thursday, May 7, 2020AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV)
Partner News | Published: Monday, May 4, 2020As we emerge from the unprecedented COVID-19 crisis, programs across the country are seeking a safe, rational approach to re-opening their Cath Labs and resuming elective revascularization. MedAxiom Industry